Skip to main content

Advertisement

Table 5 Associations of 1-year INT changes of single acylcarnitines(Dif) and combined indexes with eGFR Change(T2/T1)(Log2 transformed)

From: Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy

Log2(eGFR Change),INT(CarDif) Adjust T1GFR + T1Carnitine + Age + Sex
β SE P
Free carnitine (C0) −0.49 0.13 0.007492944
Acetylcarnitine (C2) −0.34 0.13 0.06034281
Butyrylcarnitine (C4) −0.43 0.12 0.008221232
semi Tiglyl-carnitine (C5:1) −0.12 0.12 0.599218799
Valerylcarnitine (C5) −0.37 0.14 0.042476427
semi Octanenoylcarnitine (C8:1) −0.29 0.11 0.042476427
Octanoylcarnitine (C8) 0.02 0.13 0.981932317
Malonylcarnitine (C3DC) −0.37 0.1 0.008221232
C10:1 −0.11 0.14 0.70587576
Decanoylcarnitine (C10) 0.02 0.13 0.981932317
C5DC −0.21 0.09 0.087001606
semi Dodecenoylcarnitine (C12:1) −0.17 0.12 0.42430295
Dodecanoylcarnitine (C12) −0.01 0.13 0.981932317
semi 3-Hydroxydodecanoylcarnitne (C12OH) −0.15 0.12 0.513747479
C14:1 0 0.14 0.981932317
Myristoylcarnitine (C14) 0.01 0.12 0.981932317
semi (C16:2) −0.17 0.12 0.42430295
semi Palmitoleylcarnitine (C16:1) −0.16 0.12 0.426208624
Palmitoylcarnitine (C16) −0.11 0.12 0.645845281
semi Sebacylcarnitine (C10DC) −0.09 0.13 0.732411215
semi Linoleylcarnitine(C18:2) 0.05 0.12 0.934179803
semi Oleylcarnitine (C18:1) −0.03 0.12 0.981932317
semi Stearoylcarnitine (C18) −0.07 0.13 0.870583478
semi C12DC −0.11 0.13 0.70587576
semi 3-Hydroxylinoleyl(C18:2OH) −0.02 0.14 0.981932317
semi Arachidoylcarnitine (C20) −0.19 0.13 0.42430295
  1. β effect size, SE standard error
  2. P value was adjusted with BH correction